TyG index | HR (95% CI) |
---|
Model 1 | Model 2 | Model 3 |
---|
Per 1 Unit increase | 1.97 (1.42–2.74)** | 1.57 (1.07–2.29)* | 1.94 (1.20–3.14)* |
Per 1 SD increase | 1.47 (1.22–1.76)** | 1.29 (1.04–1.60)* | 1.45 (1.11–1.91)* |
Tertile 1 | 1 (Reference) | 1 (Reference) | 1 (Reference) |
Tertile 2 | 1.94 (1.10–3.32)* | 1.58 (0.91–2.75) | 1.55 (0.87–2.78) |
Tertile 3 | 2.70 (1.59–4.58)** | 1.99 (1.12–3.52)* | 2.17 (1.15–4.06)* |
p for trend |  < 0.001 | 0.020 | 0.016 |
- Model 1: adjusted for age and gender
- Model 2: adjusted for variables with p-value < 0.05 in univariate analysis, including BMI, multivessel disease, current smoking, DM, hypertension, LDL-C, stains and hypoglycemic drugs
- Model 3: adjusted for age, gender, BMI, LVEF, admission for MI, multivessel disease, GS, current smoking, current drinking, FH-CAD, DM, hypertension, hyperlipidemia, TC, LDL-C, HDL-C, eGFR, UA, antiplatelet drugs, statins, beta-blockers, ACEI/ARB and hypoglycemic drugs
- MACE major adverse cardiovascular events, TyG index triglyceride-glucose index, HR hazard ratio, CI confidence interval, SD standard deviation
- p values in bold are < 0.05
- * p < 0.05
- ** p < 0.001